JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Alcon Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

76.16 -0.21

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

76.16

Max

76.33

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-167M

183M

Pardavimai

123M

2.6B

P/E

Sektoriaus vid.

34.935

37.461

Dividendų pajamingumas

0.44

Pelno marža

7.058

Darbuotojai

25,000

EBITDA

-213M

250M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+29.07% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.44%

2.33%

Kitas uždarbis

2025-11-11

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-6.5B

37B

Ankstesnė atidarymo kaina

76.37

Ankstesnė uždarymo kaina

76.16

Naujienos nuotaikos

By Acuity

50%

50%

147 / 371 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Alcon Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-09-02 23:07; UTC

Įsigijimai, susijungimai, perėmimai

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2025-08-20 17:21; UTC

Uždarbis
Pagrindinės rinkos jėgos

Alcon Shares Sink After Cut to Fiscal Year Sales Guidance

2025-08-20 08:46; UTC

Uždarbis
Pagrindinės rinkos jėgos

Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit

2025-08-05 10:10; UTC

Įsigijimai, susijungimai, perėmimai

Alcon to Buy Staar Surgical for $1.5 Billion

2025-05-14 15:56; UTC

Uždarbis
Pagrindinės rinkos jėgos

Alcon Shares Fall After Lowering 2025 Outlook

2025-10-08 15:44; UTC

Įsigijimai, susijungimai, perėmimai

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

2025-10-08 15:44; UTC

Įsigijimai, susijungimai, perėmimai

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

2025-10-08 15:43; UTC

Įsigijimai, susijungimai, perėmimai

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

2025-10-06 11:32; UTC

Įsigijimai, susijungimai, perėmimai

Staar Surgical: Broadwood Presentation Recycles Flawed, Misleading, Misinformed Claims About Process and Considerations Leading Up to STAAR's Agreement With Alcon

2025-09-26 21:56; UTC

Įsigijimai, susijungimai, perėmimai

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

2025-09-22 11:15; UTC

Įsigijimai, susijungimai, perėmimai

STAAR Surgical Announces Expiration of 'Window Shop' Period; No Competing Acquisition Proposals Received

2025-09-16 13:12; UTC

Įsigijimai, susijungimai, perėmimai

Staar Surgical Board Believes Value Provided by Alcon Merger Exceeds What STAAR Could Achieve on Standalone Basis in Foreseeable Future >STAA

2025-09-16 13:12; UTC

Įsigijimai, susijungimai, perėmimai

STAAR Board Unanimously Determined Proposed Merger With Alcon Is in Best Interests of Co, Stockholders >STAA

2025-09-16 13:11; UTC

Įsigijimai, susijungimai, perėmimai

Staar Surgical Will Hold Special Meeting of Stockholders on Oct 23 >STAA

2025-09-16 13:10; UTC

Įsigijimai, susijungimai, perėmimai

STAAR Surgical Bd of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

2025-08-20 17:06; UTC

Uždarbis
Pagrindinės rinkos jėgos

Alcon Shares Sink After Cut to FY Sales Guidance

2025-08-19 20:32; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Alcon Cuts 2025 View To Sales $10.3B-$10.4B >ALC.EB

2025-08-19 20:31; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Alcon 2Q EPS 35c >ALC.EB

2025-08-19 20:30; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Alcon 2Q Sales $2.58B >ALC.EB

2025-08-19 20:30; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr And Announced Acquisition Of STAAR Surgical >ALC

2025-08-08 13:40; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Staar Surgical's Top Holder Questions Deal -- Market Talk

2025-08-05 05:07; UTC

Įsigijimai, susijungimai, perėmimai

Alcon Deal Puts STARR Equity Value at Approximately $1.5 Billion. >ALC.EB

2025-08-05 05:07; UTC

Įsigijimai, susijungimai, perėmimai

Alcon Will Purchase All Outstanding Shares of STAAR Common Stock for $28 Per Share in Cash >ALC.EB

2025-08-05 05:07; UTC

Įsigijimai, susijungimai, perėmimai

Alcon Deal Represents 51% Premium to Closing Price of STAAR Common Stock on Aug. 4 >ALC.EB

2025-08-05 05:07; UTC

Įsigijimai, susijungimai, perėmimai

Alcon Agrees to Acquire STAAR Surgical >ALC STAA

2025-08-05 05:01; UTC

Įsigijimai, susijungimai, perėmimai

Alcon Agrees To Acquire STAAR Surgical >ALC STAA

2025-07-07 12:00; UTC

Įsigijimai, susijungimai, perėmimai

Alcon To Acquire LumiThera And Its Photobiomodulation Device For The Treatment Of Early And Intermediate Dry Age-Related Macular Degeneration (AMD) >ALC

2025-05-30 06:32; UTC

Rinkos pokalbiai
Uždarbis

Alcon's First FDA Approval Since Listing Is Positive, But Expected -- Market Talk

2025-05-22 20:46; UTC

Įsigijimai, susijungimai, perėmimai

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

2025-05-13 20:32; UTC

Uždarbis

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

Akcijų palyginimas

Kainos pokytis

Alcon Inc Prognozė

Kainos tikslas

By TipRanks

29.07% į viršų

12 mėnesių prognozė

Vidutinis 98.2 USD  29.07%

Aukščiausias 119.426 USD

Žemiausias 77.53 USD

Remiantis 20 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Alcon Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

20 ratings

15

Pirkti

5

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

95.77 / 97.61Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Strong Bullish Evidence

Rinkos nuotaikos

By Acuity

147 / 371 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat